PATH | VRL
Menu

Find resources

Total results with these characteristics: 66

Topic: Vaccine stabilization and formulation

Page 4 of 4
Vaccine Technologies at PATH

PATH and its partners have been advancing innovative vaccine technologies for more than 30 years. This report outlines PATH's approach and capabilities. It also describes a number of individual vaccine technologies at various …

Author: PATH

Publication date: 2010

Vaccines Against Seasonal and Pandemic Influenza and the Implications of Changes in Substrates for Virus Production

This article, published in Clincial Infectious Diseases, examines the challenges of producing influenza vaccines. Influenza virus changes contantly, which means vaccines must change to keep up—a complex collaboration between surveillance …

Author: Plotkin S, Minor PD

Publication date: 2010

Vaccines in Fast-Dissolving Tablets: Novel Product Format to Ensure Vaccine Effectiveness, Affordability, and Ease of Use

This fact sheet provides an overview of PATH's work in developing fast-dissolving tablet vaccine formulations that are manufactured using a standard lyophilization process. The small tablets are packaged in unit-dose blisters offering an …

Author: PATH

Publication date: 2015

Vaccines With Aluminum-Containing Adjuvants: Optimizing Vaccine Efficacy and Thermal Stability

Aluminum-containing adjuvants have been in use in vaccines for decades to enhance immune responses. However, exposure of vaccines containing these adjuvants to temperatures outside of the recommended storage ranges (especially exposure to freezing …

Author: Clapp T, Siebert P, Chen D, Jones Braun L

Publication date: 2010

What Vaccine Product Attributes Do Immunization Program Stakeholders Value? Results From Interviews in Six Low- and Middle-Income Countries

This article, published in Vaccine, reports the results of a study that aimed to capture the opinions of stakeholders working in immunization programs in low- and middle-income countries in order to understand how vaccine products could be improved …

Author: Kristensen DD, Bartholomew K, Villadiego S, Lorenson K

Publication date: 2016

WHO/Health Canada Drafting Group Meeting on Scientific and Regulatory Considerations on the Stability Evaluation of Vaccines Under Controlled Temperature Chain

On December 4 to 6, 2012, a consultation was held under the auspices of the World Health Organization (WHO) and Health Canada in Ottawa to identify obstacles to further developing a controlled temperature chain for vaccines. As described in this …

Author: World Health Organization

Publication date: 2013

Page 4 of 4